THE TREND OF ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION PATIENTS AFTER PERCUTANEOUS CORONARY INTERVENTION IN KOREA: A SINGLE CENTER EXPERIENCE

被引：0
|
作者：
Kim, M. J. [1 ]
Jeon, W. J. [1 ]
Park, J. J. [1 ]
Oh, I. Y. [1 ]
Yoon, C. H. [1 ]
Suh, J. W. [1 ]
Cho, Y. S. [1 ]
Youn, T. J. [1 ]
Chae, I. H. [1 ]
Choi, D. J. [1 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Dept Cardiol, Cardiovasc Ctr, Songnam, South Korea
来源：
ATHEROSCLEROSIS | 2015年 / 241卷 / 01期
关键词：
D O I：
10.1016/j.atherosclerosis.2015.04.996
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EAS-0714
引用
收藏
页码：E209 / E209
页数：1
相关论文
共 50 条
  • [31] Utilization of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
    Hye-Jeong Choi
    Yonghyuk Lee
    Susin Park
    Nam Kyung Je
    European Journal of Clinical Pharmacology, 2023, 79 : 541 - 551
  • [32] The Optimal Antithrombotic Therapy for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention With Stenting
    Iwasaki, Yusuke
    Fukunami, Masatake
    Yamada, Takahisa
    Okuyama, Yuji
    Morita, Takasi
    Sanada, Shoji
    Furukawa, Yoshio
    Masuda, Masaharu
    Yasui, Taku
    Ueda, Hiromichi
    Okada, Takeshi
    Kawasaki, Masato
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A429 - A429
  • [33] Triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a viewpoint
    Gwyn, Jennifer C. V.
    Thomas, Mark R.
    Kirchhof, Paulus
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2017, 3 (03) : 157 - 162
  • [34] Utilization of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
    Choi, Hye-Jeong
    Lee, Yonghyuk
    Park, Susin
    Je, Nam Kyung
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (04) : 541 - 551
  • [35] The role of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
    Fanaroff, Alexander C.
    Lopes, Renato D.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2021, 69 : 11 - 17
  • [36] Evolving Field of Long-term Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation
    Kiviniemi, Tuomas O.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2019, 358 (02): : 91 - 92
  • [37] Oral Anticoagulation and antithrombotic Therapy in Patients with Atrial Fibrillation after percutaneous Coronary Intervention - with special Reference to Dabigatran
    Huber, K.
    Delle Karth, G.
    Frank, H.
    Gremmel, T.
    Madl, C.
    Niessner, A.
    Neunteufl, T.
    Pirker, W.
    Watschinger, B.
    Weidinger, F.
    Weiss, T.
    Hoppe, U.
    Auer, J.
    Binder, R. K.
    Siostrzonek, P.
    Steinwender, C.
    Sturmberger, T.
    Vosko, M.
    Wallner, H.
    Zweiker, R.
    Alber, H.
    Dritan, K.
    Kirsch, A.
    Kneihsl, M.
    Raggam, R.
    Scherr, D.
    Stadlbauer-Koellner, V.
    Zirlik, A.
    JOURNAL FUR KARDIOLOGIE, 2020, 27 : 3 - 12
  • [38] CLOPIDOGREL AND COUMADIN THERAPY COMPARED TO TRIPLE ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION AFTER PERCUTANEOUS CORONARY INTERVENTION
    Badri, Vinil Kumar
    Kodumuri, Vamsi
    Singh, Param
    Khosla, Sandeep
    Arora, Rohit
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A413 - A413
  • [39] Duration of triple antithrombotic therapy and clinical outcomes after percutaneous coronary intervention in atrial fibrillation
    Sammut, Mark A.
    Conway, Dwayne
    Iqbal, Javaid
    Krishnamurthy, Arvindra
    Morgan, Kenneth P.
    Morris, Paul D.
    Richardson, James D.
    Rothman, Alexander M. K.
    Gunn, Julian P.
    Storey, Robert F.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2024, 22 (07) : 339 - 345
  • [40] Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Panov, A. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2021, 17 (04) : 628 - 637
12345